These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1375956

  • 21. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 22. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU, Bosslet K, Dickneite G, Lüben G, Sedlacek HH.
    Behring Inst Mitt; 1984 May 01; (74):157-73. PubMed ID: 6383322
    [Abstract] [Full Text] [Related]

  • 23. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL, Chourmouzis E, Victorino L, MacIntyre JP, Capetola RJ, Lau CY.
    J Immunol; 1993 Sep 15; 151(6):3007-17. PubMed ID: 8376766
    [Abstract] [Full Text] [Related]

  • 24. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
    Yun YS, Hargrove ME, Ting CC.
    J Immunol; 1988 Aug 15; 141(4):1390-7. PubMed ID: 3260924
    [Abstract] [Full Text] [Related]

  • 25. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 26. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM, Haspel MV, Parker DC, Holmes KV.
    J Immunol; 1986 Feb 15; 136(4):1454-60. PubMed ID: 3003199
    [Abstract] [Full Text] [Related]

  • 27. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
    Santoni A, Piccoli M, Ortaldo JR, Mason L, Wiltrout RH, Herberman RB.
    J Immunol; 1985 Apr 15; 134(4):2799-810. PubMed ID: 2579157
    [Abstract] [Full Text] [Related]

  • 28. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT, Eisenthal A, Rosenberg SA.
    J Immunol; 1988 Jun 01; 140(11):4062-9. PubMed ID: 3259603
    [Abstract] [Full Text] [Related]

  • 29. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
    Acha-Orbea H, Groscurth P, Lang R, Stitz L, Hengartner H.
    J Immunol; 1983 Jun 01; 130(6):2952-9. PubMed ID: 6189907
    [Abstract] [Full Text] [Related]

  • 30. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
    Shaw SG, Maung AA, Steptoe RJ, Thomson AW, Vujanovic NL.
    J Immunol; 1998 Sep 15; 161(6):2817-24. PubMed ID: 9743341
    [Abstract] [Full Text] [Related]

  • 31. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW, Trimble WS, Hozumi N, Roder JC.
    J Immunol; 1987 Jun 01; 138(11):3996-4003. PubMed ID: 3495578
    [Abstract] [Full Text] [Related]

  • 32. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
    Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M.
    Cytokine; 1999 Aug 01; 11(8):593-9. PubMed ID: 10433806
    [Abstract] [Full Text] [Related]

  • 33. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation.
    Thompson RA, Ballas ZK.
    J Immunol; 1990 Nov 15; 145(10):3524-31. PubMed ID: 1700014
    [Abstract] [Full Text] [Related]

  • 34. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1.
    Brandt CR, Salkowski CA.
    Invest Ophthalmol Vis Sci; 1992 Jan 15; 33(1):113-20. PubMed ID: 1370438
    [Abstract] [Full Text] [Related]

  • 35. The immunostimulatory compound 7-allyl-8-oxoguanosine (loxoribine) induces a distinct subset of murine cytokines.
    Pope BL, MacIntyre JP, Kimball E, Lee S, Zhou L, Taylor GR, Goodman MG.
    Cell Immunol; 1995 May 15; 162(2):333-9. PubMed ID: 7743561
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antimetastatic activity induced by Clostridium butyricum and characterization of effector cells.
    Chen HY, Wu SL, Yeh MY, Chen CF, Mikami Y, Wu JS.
    Anticancer Res; 1993 May 15; 13(1):107-11. PubMed ID: 8476200
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.